China Tobacco Hong Kong (06055.HK) 2024 Mid-Year Report: Total Revenue Up 12% to 8.7B HKD, NGPs Soar by 28%

Business by 2FIRSTS.ai
Aug.28.2024
China Tobacco Hong Kong (06055.HK) 2024 Mid-Year Report: Total Revenue Up 12% to 8.7B HKD, NGPs Soar by 28%
China Tobacco Hong Kong (06055.HK) revealed its mid-term financial report for 2024 on August 27. Company's total revenue rose 12%.

On August 27th, China Tobacco Hong Kong (06055.HK) released its interim performance report for 2024. During the period, the company's revenue reached 8.704 billion Hong Kong dollars, a 12% increase compared to the previous year; the company's attributable profit to equity holders reached 643 million Hong Kong dollars, a 41% increase year-on-year; and gross profit reached 964 million Hong Kong dollars, a 29% increase year-on-year.

China Tobacco Hong Kong (06055.HK) 2024 Mid-Year Report: Total Revenue Up 12% to 8.7B HKD, NGPs Soar by 28%
Image source: China Tobacco Hong Kong

 

  • The export business of new tobacco products has seen an increase in operating income, reaching 43.5 million Hong Kong dollars, a 28% year-on-year growth, with gross profit increasing by 57%. 
  • Cigarette export business has grown rapidly, with operating income reaching 547.3 million Hong Kong dollars, a 128% year-on-year growth, and gross profit increasing by 223%. 
  • The import and export of tobacco leaf products have seen stable growth, with import business income increasing by 5% year-on-year, and export business operating income increasing by 23% year-on-year. 
  • Operating income from business operations in Brazil has increased by 43% year-on-year, with gross profit decreasing by 8%.

 

The report reveals:

 

The company's growth in the new tobacco product sector is mainly attributed to tapping into key market channels, increasing customer marketing efforts, resulting in increased demand for orders in key markets; as well as continuously expanding their product portfolio, optimizing product pricing strategies, and increasing the proportion of self-operated business.

 

The company stated that the significant growth in cigarette export business was due to the continuous optimization of product portfolio, increased investment in new products, expansion of self-operated business, leading to a substantial increase in revenue and gross profit from cigarette export business. Additionally, foot traffic in duty-free markets has been steadily recovering, leading to improved product turnover compared to the same period last year.

 

Due to seasonal fluctuations in tobacco leaf production and an increase in the selling price of tobacco products, Chinese tobacco company CNTC's tobacco import business in Hong Kong saw a slight growth. The growth in tobacco export business is beneficial for increasing demand in the international market and optimizing pricing strategies.

 

Despite a significant increase in operating income in Brazil, gross profit has actually decreased compared to the same period last year. The company stated that this is due to a significant increase in the proportion of finished cigarette sales with high selling prices but low gross margins, while the proportion of product sales with high gross margins but lower selling prices has decreased.

 

In addition, China Tobacco Hong Kong stated that in the second half of this year, they will continue to enhance the international visibility of new tobacco products, deepen cooperation between production and sales, and comprehensively promote innovation in new tobacco technology and product upgrades.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Attorney General Stephen J. Cox has sent notices to more than 1,500 tobacco retailers and distributors warning them against selling vape and nicotine pouch products that lack authorization from the U.S. Food and Drug Administration (FDA). According to the Alaska Department of Law, businesses were advised to verify products against FDA authorization databases and avoid selling unauthorized nicotine products. The action highlights how state-level enforcement is increasingly extending federal product authorization requirements to retail channels.
Jul.24
South Korea’s Cigarette Smoking Rate Falls to 17.9%, E-Cigarette Use Continues to Rise
South Korea’s Cigarette Smoking Rate Falls to 17.9%, E-Cigarette Use Continues to Rise
Data released by the Korea Disease Control and Prevention Agency (KDCA) showed South Korea’s conventional cigarette smoking rate fell to 17.9% in 2025, while heated tobacco and liquid e-cigarette use continued to rise, particularly among young adults and women.
Jun.01
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
APUS has introduced the Chloe 50K disposable vape, which has appeared across U.S.-facing online retail channels including Element Vape and Vapesourcing. The device combines a purse-inspired body and chain attachment with a 20ml e-liquid capacity, 1,250mAh rechargeable battery, dual mesh coil, and battery and e-liquid indicators. It is rated for up to 50,000 puffs. The product does not appear on the FDA’s current list of authorized e-cigarettes, and U.S. retail availability does not indicate FDA marketing authorization.
Jul.15
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21